Parker A - Search Results

1

Inverse association between programmed death ligand 1 and genes in the VEGF pathway in primary clear cell renal cell carcinoma.

Joseph RW, Parasramka M, Eckel-Passow JE, Serie D, Wu K, Jiang L, Kalari K, Thompson RH, Huu Ho T, Castle EP, Cheville J, Kwon ED, Thompson EA, Parker A. Joseph RW, et al. Among authors: parker a. Cancer Immunol Res. 2013 Dec;1(6):378-85. doi: 10.1158/2326-6066.CIR-13-0042. Epub 2013 Aug 29. Cancer Immunol Res. 2013. PMID: 24778130 Free PMC article.

2

High expression levels of insulin-like growth factor-I receptor predict poor survival among women with clear-cell renal cell carcinomas.

Parker AS, Cheville JC, Janney CA, Cerhan JR. Parker AS, et al. Hum Pathol. 2002 Aug;33(8):801-5. doi: 10.1053/hupa.2002.126186. Hum Pathol. 2002. PMID: 12203212

3

Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials.

Leibovich BC, Blute ML, Cheville JC, Lohse CM, Frank I, Kwon ED, Weaver AL, Parker AS, Zincke H. Leibovich BC, et al. Cancer. 2003 Apr 1;97(7):1663-71. doi: 10.1002/cncr.11234. Cancer. 2003. PMID: 12655523 Free article.

4

Expression of insulin-like growth factor I receptor and survival in patients with clear cell renal cell carcinoma.

Parker A, Cheville JC, Lohse C, Cerhan JR, Blute ML. Parker A, et al. J Urol. 2003 Aug;170(2 Pt 1):420-4. doi: 10.1097/01.ju.0000071474.70103.92. J Urol. 2003. PMID: 12853790

5

Pathologic T1 clear cell renal cell carcinoma: insulin-like growth factor-I receptor expression and disease-specific survival.

Parker AS, Cheville JC, Blute ML, Igel T, Lohse CM, Cerhan JR. Parker AS, et al. Cancer. 2004 Jun 15;100(12):2577-82. doi: 10.1002/cncr.20322. Cancer. 2004. PMID: 15197799 Free article.

6

Loss of expression of von Hippel-Lindau tumor suppressor protein associated with improved survival in patients with early-stage clear cell renal cell carcinoma.

Parker AS, Cheville JC, Lohse CM, Igel T, Leibovich BC, Blute ML. Parker AS, et al. Urology. 2005 Jun;65(6):1090-5. doi: 10.1016/j.urology.2004.12.040. Urology. 2005. PMID: 15893810

7

Clear cell renal cell carcinoma: gene expression analyses identify a potential signature for tumor aggressiveness.

Kosari F, Parker AS, Kube DM, Lohse CM, Leibovich BC, Blute ML, Cheville JC, Vasmatzis G. Kosari F, et al. Clin Cancer Res. 2005 Jul 15;11(14):5128-39. doi: 10.1158/1078-0432.CCR-05-0073. Clin Cancer Res. 2005. PMID: 16033827

8

Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up.

Thompson RH, Kuntz SM, Leibovich BC, Dong H, Lohse CM, Webster WS, Sengupta S, Frank I, Parker AS, Zincke H, Blute ML, Sebo TJ, Cheville JC, Kwon ED. Thompson RH, et al. Cancer Res. 2006 Apr 1;66(7):3381-5. doi: 10.1158/0008-5472.CAN-05-4303. Cancer Res. 2006. PMID: 16585157

9

High expression levels of survivin protein independently predict a poor outcome for patients who undergo surgery for clear cell renal cell carcinoma.

Parker AS, Kosari F, Lohse CM, Houston Thompson R, Kwon ED, Murphy L, Riehle DL, Blute ML, Leibovich BC, Vasmatzis G, Cheville JC. Parker AS, et al. Cancer. 2006 Jul 1;107(1):37-45. doi: 10.1002/cncr.21952. Cancer. 2006. PMID: 16736510 Free article.

10

Greater body mass index is associated with better pathologic features and improved outcome among patients treated surgically for clear cell renal cell carcinoma.

Parker AS, Lohse CM, Cheville JC, Thiel DD, Leibovich BC, Blute ML. Parker AS, et al. Urology. 2006 Oct;68(4):741-6. doi: 10.1016/j.urology.2006.05.024. Urology. 2006. PMID: 17070345

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,334 results

Search Page